title: Therapeutic challenges in childhood sickle cell disease. Part 1: current and future treatment options.
authors.affiliation: Department of Bone Marrow Transplantation, Great Ormond Street Hospital for Sick Children, London, UK. amrolp1@gosh.nhs.uk
authors.forename: Persis J
authors.initials: PJ
authors.lastname: Amrolia
authors.forename: Antonio
authors.initials: A
authors.lastname: Almeida
authors.forename: Christina
authors.initials: C
authors.lastname: Halsey
authors.forename: Irene A G
authors.initials: IA
authors.lastname: Roberts
authors.forename: Sally C
authors.initials: SC
authors.lastname: Davies
mesh_terms: D000755:Anemia, Sickle Cell / Q000628:therapy*; D000986:Antisickling Agents / Q000627:therapeutic use; D016026:Bone Marrow Transplantation / Q000379:methods; D015815:Cell Adhesion Molecules / Q000037:antagonists & inhibitors; D002648:Child; D002986:Clinical Trials as Topic; D017707:Erythrocyte Transfusion / Q000379:methods; D005232:Fatty Acids, Volatile / Q000627:therapeutic use; D005312:Fetal Blood / Q000637:transplantation; D015316:Genetic Therapy; D006801:Humans; D006918:Hydroxyurea / Q000627:therapeutic use; D018579:Patient Selection; D033581:Stem Cell Transplantation / Q000379:methods
chemical_list: D000986:Antisickling Agents; D015815:Cell Adhesion Molecules; D005232:Fatty Acids, Volatile; D006918:Hydroxyurea